A
Agilent Technologies, Inc.
Set alert
- YTD
- +28.51%
- 1 year
- +21.98%
- Open
- 180.98
- Prev close
- 181.15
- Mkt cap
- 49.30B
- Vol
- 2.76M
- Avg vol
- 2.22M
- EPS
- 5.07
- P/E
- 34.49
- Div yield
- 0.56%
More statistics
- Low
- 173.38
- High
- 180.80
- Forward P/E
- 26.06
- Beta
- 1.21
- Short ratio
- 2.03
- Inst. own
- 95.41%
- Dividend
- 1.02
- Ex-div date
- Oct 5, 2026
- Earnings
- Nov 23, 2026
- 50-d avg
- 163.72
- 200-d avg
- 135.91
- 1y target
- 182.05
Key statistics
- Market cap
- 49.44B
- Enterprise value
- 53.46B
- Trailing P/E
- 34.59
- Forward P/E
- 26.06
- PEG ratio
- 1.53
- Price / sales
- 6.71
- Price / book
- 6.72
- EPS (TTM)
- 5.07
- Beta
- 1.21
- Dividend yield
- 0.56%
- Payout ratio
- 19.98%
- Profit margin
- 19.53%
- Revenue (TTM)
- 7.37B
- Revenue growth
- 8.10%
- Free cash flow
- 1.06B
- Total cash
- 1.76B
- Total debt
- 4.15B
- Return on equity
- 20.97%
- Shares outstanding
- 281.97M
- Short % of float
- 2.03%
- 50-day average
- 163.72
- 200-day average
- 135.91
Analyst view
Consensus: buy
- Target (low)
- 155.00
- Target (mean)
- 182.05
- Target (high)
- 200.00
- Strong buy3
- Buy12
- Hold7
- Sell0
- Strong sell0
Next earnings
Nov 23, 2026
Expected Nov 23, 2026. Consensus EPS estimate 1.73.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 23, 2026 | Oct 31, 2026 | 1.73 | — | — | — |
| Aug 26, 2026 | Jul 31, 2026 | 1.49 | 1.62 | +0.13 | +8.72% |
| May 27, 2026 | Apr 30, 2026 | 1.41 | 1.49 | +0.08 | +5.67% |
| Feb 25, 2026 | Jan 31, 2026 | 1.37 | 1.36 | -0.01 | -0.73% |
| Nov 24, 2025 | Oct 31, 2025 | 1.58 | 1.59 | +0.01 | +0.36% |
| Aug 27, 2025 | Jul 31, 2025 | 1.37 | 1.37 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 26, 2026 | Deutsche Bank | init | — | Buy |
| Oct 13, 2026 | TD Cowen | main | Buy | Buy |
| Oct 13, 2026 | Morgan Stanley | main | Overweight | Overweight |
| Oct 7, 2026 | Barclays | main | Overweight | Overweight |
| Aug 28, 2026 | Wells Fargo | main | Overweight | Overweight |
| Aug 27, 2026 | Stifel | main | Buy | Buy |
About Agilent Technologies, Inc.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- agilent.com
News
- Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23
- Parnassus Mid Cap Growth Fund: Q3 2026 Performance Review
- Parnassus Mid Cap Fund Q3 2026 Portfolio Review
- Carillon Scout Mid Cap Fund Q3 2026 Portfolio Review
- Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research
- Dividend Champion, Contender, And Challenger Highlights: Week October 25
- $1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
- Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist
- TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $196
- Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $190
Your note
Sign in to keep a note on A — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANCHER JENSEN HENRIK | Officer | Stock Award(Grant) | Nov 26, 2024 | 90,674 |
| FIELDS-KUNZ HEIDI | Director | Stock Award(Grant) | Mar 13, 2025 | 0 |
| GONSALVES RODNEY | Officer | Stock Gift | Nov 25, 2025 | 0 |
| KOH BOON HWEE | Director | Stock Award(Grant) | Mar 18, 2026 | 63,184 |
| MCDONNELL PADRAIG | Chief Executive Officer | Stock Award(Grant) | Nov 17, 2025 | 69,028 |
| MCMAHON ROBERT W | Chief Financial Officer | Stock Award(Grant) | Mar 4, 2025 | 172,191 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.08% | 25,599,001 | 4.49B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.54% | 18,449,861 | 3.24B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.12% | 14,442,441 | 2.53B | Jun 29, 2026 |
| State Street Corporation | 4.56% | 12,854,230 | 2.25B | Jun 29, 2026 |
| Massachusetts Financial Services Co. | 3.55% | 10,010,867 | 1.76B | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 2.75% | 7,756,921 | 1.36B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.18% | 8,960,777 | 1.57B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.60% | 7,323,357 | 1.28B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.17% | 6,115,378 | 1.07B | Jun 29, 2026 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 1.46% | 4,107,878 | 720.32M | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.46% | 4,119,810 | 722.41M | Jul 30, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 3,763,584 | 659.94M | Sep 29, 2026 |